AMNOG
Evidence Graph
Ask
Cases
Sources
Explore / Assessment
Assessment
Ivacaftor/tezacaftor/elexacaftor
Digestion, metabolism and hormones
Modules
IQWiG assessments · G-BA decisions
Connections
2
Connected evidence
2 relations
owns document
1
Outgoing
Nutzenbewertung IQWiG
Document
has assessment · incoming
1
Incoming
Ivacaftor/Tezacaftor/Elexacaftor (Neues Anwendungsgebiet: Zystische Fibrose, Kombinationsbehandlung mit Ivacaftor, ≥ 2 Jahre, Nicht-Klasse-I-Mutation (keine F508del-Mutation und keine Gating-Mutation))
Procedure